Related Experiment Videos

It is not time to stop progesterone receptor testing in breast cancer

R Colomer, M Beltran, J Dorcas

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|June 1, 2005

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

HER2DX in early-stage HER2-positive breast cancer: a review of clinical utility.

ESMO open·2026

Primary results from EL1SSAR, a prospective phase IIIb study of first-line atezolizumab plus nab-paclitaxel therapy for patients with PD-L1-positive advanced triple-negative breast cancer.

Breast (Edinburgh, Scotland)·2026

Analysis of UGT1A1 germline variants in patients with advanced breast cancer treated with trastuzumab-deruxtecan: results from the PROCURE Project.

ESMO open·2026

Test of the Gravitational Force Law on Cosmological Scales Using the Kinematic Sunyaev-Zeldovich Effect.

Physical review letters·2026

Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial.

ESMO open·2025

Palbociclib and trastuzumab for HER2-positive metastatic breast cancer: final overall survival results of cohort A and B of SOLTI-1303-PATRICIA trial.

ESMO open·2025

See all related articles